{"id":"W4409595460","doi":"10.1016/j.lungcan.2025.108551","title":"Osimertinib vs. Afatinib in 1L therapy of atypical EGFR-mutated metastatic non-small cell lung cancer (mNSCLC): A multi-institution, real-world survival analysis","year":2025,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Takeda Pharmaceutical Company; Takeda Pharmaceuticals U.S.A.; AstraZeneca; LUNGevity Foundation","keywords":"Medicine; Afatinib; Osimertinib; Oncology; Lung cancer; Internal medicine; Cancer; Erlotinib; Epidermal growth factor receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000226768,0.000358125,0.001009327,0.0007730688,0.0001183041,0.00002585373,0.0001735559,0.0001035341,0.0005491671],"category_scores_gemma":[0.00003101489,0.0002952432,0.0003307547,0.003095286,0.0001298993,0.0001067985,0.00004235806,0.0002824016,0.000002994864],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001047663,"about_ca_system_score_gemma":0.001640715,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.03468835,"about_ca_topic_score_gemma":0.04806835,"domain_scores_codex":[0.9976521,0.0001241807,0.0008081413,0.0006040891,0.0003397164,0.0004717536],"domain_scores_gemma":[0.9986007,0.0001475638,0.0002818968,0.0004783938,0.0003334987,0.0001580007],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001341119,0.001268936,0.9741476,0.0005405057,0.006350388,0.00004537794,0.001997486,0.007364687,0.002387115,0.0002768844,0.00116343,0.003116464],"study_design_scores_gemma":[0.01622841,0.0001209141,0.9255587,0.0008508977,0.008285303,6.641388e-7,0.0002348228,0.03785048,0.008631467,0.00001681991,0.001838603,0.0003829436],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9754516,0.01021652,0.004194464,0.001668346,0.0008875284,0.002294401,0.0002554209,0.0001001901,0.004931472],"genre_scores_gemma":[0.9878675,0.003655366,0.001440645,0.0005389342,0.00007969912,0.0009371788,0.0001707425,0.00003801336,0.005271951],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04858893,"threshold_uncertainty_score":0.99995,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02199493696951441,"score_gpt":0.3823233804007207,"score_spread":0.3603284434312062,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}